nodes	percent_of_prediction	percent_of_DWPC	metapath
Promethazine—Levomethadyl Acetate—Tamoxifen—pancreatic cancer	0.0799	0.14	CrCrCtD
Promethazine—Methadyl Acetate—Tamoxifen—pancreatic cancer	0.0799	0.14	CrCrCtD
Promethazine—Cyclobenzaprine—Tamoxifen—pancreatic cancer	0.0751	0.131	CrCrCtD
Promethazine—Dimetacrine—Tamoxifen—pancreatic cancer	0.0584	0.102	CrCrCtD
Promethazine—Methadone—Tamoxifen—pancreatic cancer	0.0548	0.0959	CrCrCtD
Promethazine—Clofedanol—Tamoxifen—pancreatic cancer	0.0474	0.0829	CrCrCtD
Promethazine—Benzphetamine—Tamoxifen—pancreatic cancer	0.0459	0.0802	CrCrCtD
Promethazine—Orphenadrine—Tamoxifen—pancreatic cancer	0.0459	0.0802	CrCrCtD
Promethazine—Promazine—Tamoxifen—pancreatic cancer	0.0438	0.0766	CrCrCtD
Promethazine—Diphenhydramine—Tamoxifen—pancreatic cancer	0.0407	0.0712	CrCrCtD
Promethazine—CYP2B6—Tamoxifen—pancreatic cancer	0.0332	0.148	CbGbCtD
Promethazine—CYP2B6—Irinotecan—pancreatic cancer	0.0255	0.113	CbGbCtD
Promethazine—CYP2C9—Tamoxifen—pancreatic cancer	0.0175	0.078	CbGbCtD
Promethazine—ABCB1—Tamoxifen—pancreatic cancer	0.017	0.0757	CbGbCtD
Promethazine—CYP2D6—Tamoxifen—pancreatic cancer	0.016	0.0713	CbGbCtD
Promethazine—ABCB1—Gemcitabine—pancreatic cancer	0.0147	0.0652	CbGbCtD
Promethazine—ABCB1—Erlotinib—pancreatic cancer	0.0145	0.0643	CbGbCtD
Promethazine—CYP2B6—Doxorubicin—pancreatic cancer	0.0139	0.0619	CbGbCtD
Promethazine—CYP2D6—Erlotinib—pancreatic cancer	0.0136	0.0606	CbGbCtD
Promethazine—ABCB1—Irinotecan—pancreatic cancer	0.0131	0.0581	CbGbCtD
Promethazine—CYP2C9—Fluorouracil—pancreatic cancer	0.0129	0.0575	CbGbCtD
Promethazine—ABCB1—Docetaxel—pancreatic cancer	0.00958	0.0426	CbGbCtD
Promethazine—ABCB1—Sunitinib—pancreatic cancer	0.00954	0.0424	CbGbCtD
Promethazine—ABCB1—Doxorubicin—pancreatic cancer	0.00714	0.0317	CbGbCtD
Promethazine—CYP2D6—Doxorubicin—pancreatic cancer	0.00673	0.0299	CbGbCtD
Promethazine—Coordination abnormal—Epirubicin—pancreatic cancer	0.000305	0.00379	CcSEcCtD
Promethazine—Injection site reaction—Epirubicin—pancreatic cancer	0.000298	0.0037	CcSEcCtD
Promethazine—Dermatitis contact—Epirubicin—pancreatic cancer	0.000296	0.00367	CcSEcCtD
Promethazine—Convulsion—Sunitinib—pancreatic cancer	0.000296	0.00367	CcSEcCtD
Promethazine—Dyskinesia—Doxorubicin—pancreatic cancer	0.000295	0.00366	CcSEcCtD
Promethazine—Insomnia—Tamoxifen—pancreatic cancer	0.000294	0.00365	CcSEcCtD
Promethazine—Insomnia—Erlotinib—pancreatic cancer	0.000291	0.00361	CcSEcCtD
Promethazine—Arrhythmia—Irinotecan—pancreatic cancer	0.000289	0.00358	CcSEcCtD
Promethazine—Dyspepsia—Tamoxifen—pancreatic cancer	0.000286	0.00355	CcSEcCtD
Promethazine—Dry mouth—Sunitinib—pancreatic cancer	0.000284	0.00352	CcSEcCtD
Promethazine—Dyspepsia—Erlotinib—pancreatic cancer	0.000283	0.00351	CcSEcCtD
Promethazine—Decreased appetite—Tamoxifen—pancreatic cancer	0.000283	0.0035	CcSEcCtD
Promethazine—Coordination abnormal—Doxorubicin—pancreatic cancer	0.000283	0.0035	CcSEcCtD
Promethazine—Aplastic anaemia—Epirubicin—pancreatic cancer	0.000282	0.00349	CcSEcCtD
Promethazine—Arrhythmia—Gemcitabine—pancreatic cancer	0.000281	0.00348	CcSEcCtD
Promethazine—Fatigue—Tamoxifen—pancreatic cancer	0.00028	0.00348	CcSEcCtD
Promethazine—Decreased appetite—Erlotinib—pancreatic cancer	0.00028	0.00347	CcSEcCtD
Promethazine—Oedema—Sunitinib—pancreatic cancer	0.000279	0.00345	CcSEcCtD
Promethazine—Pain—Tamoxifen—pancreatic cancer	0.000278	0.00345	CcSEcCtD
Promethazine—Constipation—Tamoxifen—pancreatic cancer	0.000278	0.00345	CcSEcCtD
Promethazine—Fatigue—Erlotinib—pancreatic cancer	0.000277	0.00344	CcSEcCtD
Promethazine—Arrhythmia—Fluorouracil—pancreatic cancer	0.000276	0.00343	CcSEcCtD
Promethazine—Injection site reaction—Doxorubicin—pancreatic cancer	0.000276	0.00342	CcSEcCtD
Promethazine—Pain—Erlotinib—pancreatic cancer	0.000275	0.00341	CcSEcCtD
Promethazine—Constipation—Erlotinib—pancreatic cancer	0.000275	0.00341	CcSEcCtD
Promethazine—Dermatitis contact—Doxorubicin—pancreatic cancer	0.000274	0.0034	CcSEcCtD
Promethazine—Shock—Sunitinib—pancreatic cancer	0.000274	0.0034	CcSEcCtD
Promethazine—Coma—Epirubicin—pancreatic cancer	0.000274	0.0034	CcSEcCtD
Promethazine—Erythema—Gemcitabine—pancreatic cancer	0.000274	0.00339	CcSEcCtD
Promethazine—Thrombocytopenia—Sunitinib—pancreatic cancer	0.000273	0.00338	CcSEcCtD
Promethazine—Muscle spasms—Irinotecan—pancreatic cancer	0.00027	0.00335	CcSEcCtD
Promethazine—Erythema—Fluorouracil—pancreatic cancer	0.000269	0.00334	CcSEcCtD
Promethazine—Aplastic anaemia—Doxorubicin—pancreatic cancer	0.000261	0.00323	CcSEcCtD
Promethazine—Vision blurred—Fluorouracil—pancreatic cancer	0.000254	0.00315	CcSEcCtD
Promethazine—Coma—Doxorubicin—pancreatic cancer	0.000254	0.00314	CcSEcCtD
Promethazine—Phlebitis—Epirubicin—pancreatic cancer	0.000253	0.00313	CcSEcCtD
Promethazine—Syncope—Irinotecan—pancreatic cancer	0.000252	0.00313	CcSEcCtD
Promethazine—Insomnia—Sunitinib—pancreatic cancer	0.000252	0.00312	CcSEcCtD
Promethazine—Leukopenia—Irinotecan—pancreatic cancer	0.000252	0.00312	CcSEcCtD
Promethazine—Thrombophlebitis—Epirubicin—pancreatic cancer	0.000251	0.00312	CcSEcCtD
Promethazine—Photosensitivity—Epirubicin—pancreatic cancer	0.000248	0.00307	CcSEcCtD
Promethazine—Loss of consciousness—Irinotecan—pancreatic cancer	0.000247	0.00306	CcSEcCtD
Promethazine—Dyspepsia—Sunitinib—pancreatic cancer	0.000245	0.00304	CcSEcCtD
Promethazine—Leukopenia—Gemcitabine—pancreatic cancer	0.000245	0.00304	CcSEcCtD
Promethazine—Jaundice—Docetaxel—pancreatic cancer	0.000242	0.00301	CcSEcCtD
Promethazine—Decreased appetite—Sunitinib—pancreatic cancer	0.000242	0.003	CcSEcCtD
Promethazine—Leukopenia—Fluorouracil—pancreatic cancer	0.000241	0.00299	CcSEcCtD
Promethazine—Fatigue—Sunitinib—pancreatic cancer	0.00024	0.00298	CcSEcCtD
Promethazine—Constipation—Sunitinib—pancreatic cancer	0.000238	0.00295	CcSEcCtD
Promethazine—Pain—Sunitinib—pancreatic cancer	0.000238	0.00295	CcSEcCtD
Promethazine—Phlebitis—Doxorubicin—pancreatic cancer	0.000234	0.0029	CcSEcCtD
Promethazine—Asthenia—Tamoxifen—pancreatic cancer	0.000233	0.00289	CcSEcCtD
Promethazine—Convulsion—Fluorouracil—pancreatic cancer	0.000233	0.00289	CcSEcCtD
Promethazine—Thrombophlebitis—Doxorubicin—pancreatic cancer	0.000233	0.00288	CcSEcCtD
Promethazine—Agranulocytosis—Docetaxel—pancreatic cancer	0.000232	0.00288	CcSEcCtD
Promethazine—Confusional state—Irinotecan—pancreatic cancer	0.000231	0.00287	CcSEcCtD
Promethazine—Asthenia—Erlotinib—pancreatic cancer	0.000231	0.00286	CcSEcCtD
Promethazine—Pruritus—Tamoxifen—pancreatic cancer	0.00023	0.00285	CcSEcCtD
Promethazine—Anaphylactic shock—Irinotecan—pancreatic cancer	0.000229	0.00284	CcSEcCtD
Promethazine—Oedema—Irinotecan—pancreatic cancer	0.000229	0.00284	CcSEcCtD
Promethazine—Photosensitivity—Doxorubicin—pancreatic cancer	0.000229	0.00284	CcSEcCtD
Promethazine—Pruritus—Erlotinib—pancreatic cancer	0.000228	0.00282	CcSEcCtD
Promethazine—Shock—Irinotecan—pancreatic cancer	0.000226	0.0028	CcSEcCtD
Promethazine—Thrombocytopenia—Irinotecan—pancreatic cancer	0.000225	0.00278	CcSEcCtD
Promethazine—Oedema—Gemcitabine—pancreatic cancer	0.000224	0.00277	CcSEcCtD
Promethazine—Anaphylactic shock—Gemcitabine—pancreatic cancer	0.000224	0.00277	CcSEcCtD
Promethazine—Diarrhoea—Tamoxifen—pancreatic cancer	0.000223	0.00276	CcSEcCtD
Promethazine—Confusional state—Fluorouracil—pancreatic cancer	0.000222	0.00275	CcSEcCtD
Promethazine—Diarrhoea—Erlotinib—pancreatic cancer	0.00022	0.00273	CcSEcCtD
Promethazine—Anaphylactic shock—Fluorouracil—pancreatic cancer	0.00022	0.00272	CcSEcCtD
Promethazine—Oedema—Fluorouracil—pancreatic cancer	0.00022	0.00272	CcSEcCtD
Promethazine—Thrombocytopenia—Gemcitabine—pancreatic cancer	0.000219	0.00271	CcSEcCtD
Promethazine—Diplopia—Epirubicin—pancreatic cancer	0.000218	0.0027	CcSEcCtD
Promethazine—Thrombocytopenia—Fluorouracil—pancreatic cancer	0.000215	0.00267	CcSEcCtD
Promethazine—Dizziness—Tamoxifen—pancreatic cancer	0.000215	0.00267	CcSEcCtD
Promethazine—Tachycardia—Fluorouracil—pancreatic cancer	0.000214	0.00266	CcSEcCtD
Promethazine—Hypotension—Irinotecan—pancreatic cancer	0.000214	0.00266	CcSEcCtD
Promethazine—Dizziness—Erlotinib—pancreatic cancer	0.000213	0.00264	CcSEcCtD
Promethazine—Hypotension—Gemcitabine—pancreatic cancer	0.000209	0.00259	CcSEcCtD
Promethazine—Insomnia—Irinotecan—pancreatic cancer	0.000208	0.00257	CcSEcCtD
Promethazine—Hypotension—Fluorouracil—pancreatic cancer	0.000205	0.00255	CcSEcCtD
Promethazine—Rash—Tamoxifen—pancreatic cancer	0.000205	0.00254	CcSEcCtD
Promethazine—Dermatitis—Tamoxifen—pancreatic cancer	0.000205	0.00254	CcSEcCtD
Promethazine—Somnolence—Irinotecan—pancreatic cancer	0.000204	0.00253	CcSEcCtD
Promethazine—Headache—Tamoxifen—pancreatic cancer	0.000204	0.00253	CcSEcCtD
Promethazine—Rash—Erlotinib—pancreatic cancer	0.000203	0.00252	CcSEcCtD
Promethazine—Dermatitis—Erlotinib—pancreatic cancer	0.000203	0.00251	CcSEcCtD
Promethazine—Insomnia—Gemcitabine—pancreatic cancer	0.000202	0.00251	CcSEcCtD
Promethazine—Dyspepsia—Irinotecan—pancreatic cancer	0.000202	0.0025	CcSEcCtD
Promethazine—Headache—Erlotinib—pancreatic cancer	0.000202	0.0025	CcSEcCtD
Promethazine—Diplopia—Doxorubicin—pancreatic cancer	0.000201	0.0025	CcSEcCtD
Promethazine—Asthenia—Sunitinib—pancreatic cancer	0.0002	0.00248	CcSEcCtD
Promethazine—Decreased appetite—Irinotecan—pancreatic cancer	0.000199	0.00247	CcSEcCtD
Promethazine—Arrhythmia—Docetaxel—pancreatic cancer	0.000199	0.00247	CcSEcCtD
Promethazine—Insomnia—Fluorouracil—pancreatic cancer	0.000199	0.00246	CcSEcCtD
Promethazine—Somnolence—Gemcitabine—pancreatic cancer	0.000199	0.00246	CcSEcCtD
Promethazine—Fatigue—Irinotecan—pancreatic cancer	0.000198	0.00245	CcSEcCtD
Promethazine—Pruritus—Sunitinib—pancreatic cancer	0.000197	0.00244	CcSEcCtD
Promethazine—Constipation—Irinotecan—pancreatic cancer	0.000196	0.00243	CcSEcCtD
Promethazine—Pain—Irinotecan—pancreatic cancer	0.000196	0.00243	CcSEcCtD
Promethazine—Somnolence—Fluorouracil—pancreatic cancer	0.000195	0.00242	CcSEcCtD
Promethazine—Erythema—Docetaxel—pancreatic cancer	0.000194	0.00241	CcSEcCtD
Promethazine—Decreased appetite—Gemcitabine—pancreatic cancer	0.000194	0.00241	CcSEcCtD
Promethazine—Dyspepsia—Fluorouracil—pancreatic cancer	0.000193	0.0024	CcSEcCtD
Promethazine—Fatigue—Gemcitabine—pancreatic cancer	0.000193	0.00239	CcSEcCtD
Promethazine—Pain—Gemcitabine—pancreatic cancer	0.000191	0.00237	CcSEcCtD
Promethazine—Constipation—Gemcitabine—pancreatic cancer	0.000191	0.00237	CcSEcCtD
Promethazine—Decreased appetite—Fluorouracil—pancreatic cancer	0.000191	0.00237	CcSEcCtD
Promethazine—Diarrhoea—Sunitinib—pancreatic cancer	0.000191	0.00236	CcSEcCtD
Promethazine—Feeling abnormal—Irinotecan—pancreatic cancer	0.000189	0.00234	CcSEcCtD
Promethazine—Asthma—Epirubicin—pancreatic cancer	0.000188	0.00233	CcSEcCtD
Promethazine—Pain—Fluorouracil—pancreatic cancer	0.000188	0.00233	CcSEcCtD
Promethazine—Muscle spasms—Docetaxel—pancreatic cancer	0.000187	0.00232	CcSEcCtD
Promethazine—Dizziness—Sunitinib—pancreatic cancer	0.000184	0.00228	CcSEcCtD
Promethazine—Feeling abnormal—Gemcitabine—pancreatic cancer	0.000184	0.00228	CcSEcCtD
Promethazine—Feeling abnormal—Fluorouracil—pancreatic cancer	0.000181	0.00224	CcSEcCtD
Promethazine—Rash—Sunitinib—pancreatic cancer	0.000176	0.00218	CcSEcCtD
Promethazine—Dermatitis—Sunitinib—pancreatic cancer	0.000175	0.00218	CcSEcCtD
Promethazine—Headache—Sunitinib—pancreatic cancer	0.000175	0.00216	CcSEcCtD
Promethazine—Syncope—Docetaxel—pancreatic cancer	0.000174	0.00216	CcSEcCtD
Promethazine—Asthma—Doxorubicin—pancreatic cancer	0.000174	0.00216	CcSEcCtD
Promethazine—Leukopenia—Docetaxel—pancreatic cancer	0.000174	0.00216	CcSEcCtD
Promethazine—Palpitations—Docetaxel—pancreatic cancer	0.000172	0.00213	CcSEcCtD
Promethazine—Photosensitivity reaction—Epirubicin—pancreatic cancer	0.000172	0.00213	CcSEcCtD
Promethazine—Loss of consciousness—Docetaxel—pancreatic cancer	0.000171	0.00212	CcSEcCtD
Promethazine—Convulsion—Docetaxel—pancreatic cancer	0.000168	0.00209	CcSEcCtD
Promethazine—Drowsiness—Epirubicin—pancreatic cancer	0.000168	0.00208	CcSEcCtD
Promethazine—Asthenia—Irinotecan—pancreatic cancer	0.000165	0.00204	CcSEcCtD
Promethazine—Jaundice—Epirubicin—pancreatic cancer	0.000164	0.00203	CcSEcCtD
Promethazine—Dry mouth—Docetaxel—pancreatic cancer	0.000162	0.00201	CcSEcCtD
Promethazine—Asthenia—Gemcitabine—pancreatic cancer	0.00016	0.00199	CcSEcCtD
Promethazine—Confusional state—Docetaxel—pancreatic cancer	0.00016	0.00198	CcSEcCtD
Promethazine—Photosensitivity reaction—Doxorubicin—pancreatic cancer	0.000159	0.00197	CcSEcCtD
Promethazine—Anaphylactic shock—Docetaxel—pancreatic cancer	0.000159	0.00197	CcSEcCtD
Promethazine—Oedema—Docetaxel—pancreatic cancer	0.000159	0.00197	CcSEcCtD
Promethazine—Pruritus—Gemcitabine—pancreatic cancer	0.000158	0.00196	CcSEcCtD
Promethazine—Diarrhoea—Irinotecan—pancreatic cancer	0.000157	0.00195	CcSEcCtD
Promethazine—Agranulocytosis—Epirubicin—pancreatic cancer	0.000157	0.00194	CcSEcCtD
Promethazine—Shock—Docetaxel—pancreatic cancer	0.000156	0.00193	CcSEcCtD
Promethazine—Pruritus—Fluorouracil—pancreatic cancer	0.000155	0.00193	CcSEcCtD
Promethazine—Thrombocytopenia—Docetaxel—pancreatic cancer	0.000155	0.00193	CcSEcCtD
Promethazine—Drowsiness—Doxorubicin—pancreatic cancer	0.000155	0.00192	CcSEcCtD
Promethazine—Tachycardia—Docetaxel—pancreatic cancer	0.000155	0.00192	CcSEcCtD
Promethazine—Bradycardia—Epirubicin—pancreatic cancer	0.000153	0.0019	CcSEcCtD
Promethazine—Diarrhoea—Gemcitabine—pancreatic cancer	0.000153	0.0019	CcSEcCtD
Promethazine—Dizziness—Irinotecan—pancreatic cancer	0.000152	0.00188	CcSEcCtD
Promethazine—Jaundice—Doxorubicin—pancreatic cancer	0.000151	0.00188	CcSEcCtD
Promethazine—Diarrhoea—Fluorouracil—pancreatic cancer	0.00015	0.00186	CcSEcCtD
Promethazine—Hypotension—Docetaxel—pancreatic cancer	0.000148	0.00184	CcSEcCtD
Promethazine—Dizziness—Fluorouracil—pancreatic cancer	0.000145	0.0018	CcSEcCtD
Promethazine—Agranulocytosis—Doxorubicin—pancreatic cancer	0.000145	0.0018	CcSEcCtD
Promethazine—Rash—Irinotecan—pancreatic cancer	0.000145	0.00179	CcSEcCtD
Promethazine—Dermatitis—Irinotecan—pancreatic cancer	0.000145	0.00179	CcSEcCtD
Promethazine—Headache—Irinotecan—pancreatic cancer	0.000144	0.00178	CcSEcCtD
Promethazine—Insomnia—Docetaxel—pancreatic cancer	0.000143	0.00178	CcSEcCtD
Promethazine—Bradycardia—Doxorubicin—pancreatic cancer	0.000142	0.00176	CcSEcCtD
Promethazine—Somnolence—Docetaxel—pancreatic cancer	0.000141	0.00175	CcSEcCtD
Promethazine—Rash—Gemcitabine—pancreatic cancer	0.000141	0.00175	CcSEcCtD
Promethazine—Dermatitis—Gemcitabine—pancreatic cancer	0.000141	0.00175	CcSEcCtD
Promethazine—Tinnitus—Epirubicin—pancreatic cancer	0.00014	0.00174	CcSEcCtD
Promethazine—Headache—Gemcitabine—pancreatic cancer	0.00014	0.00174	CcSEcCtD
Promethazine—Dyspepsia—Docetaxel—pancreatic cancer	0.00014	0.00173	CcSEcCtD
Promethazine—Rash—Fluorouracil—pancreatic cancer	0.000139	0.00172	CcSEcCtD
Promethazine—Dermatitis—Fluorouracil—pancreatic cancer	0.000138	0.00172	CcSEcCtD
Promethazine—Decreased appetite—Docetaxel—pancreatic cancer	0.000138	0.00171	CcSEcCtD
Promethazine—Headache—Fluorouracil—pancreatic cancer	0.000138	0.00171	CcSEcCtD
Promethazine—Fatigue—Docetaxel—pancreatic cancer	0.000137	0.0017	CcSEcCtD
Promethazine—Constipation—Docetaxel—pancreatic cancer	0.000136	0.00168	CcSEcCtD
Promethazine—Pain—Docetaxel—pancreatic cancer	0.000136	0.00168	CcSEcCtD
Promethazine—Arrhythmia—Epirubicin—pancreatic cancer	0.000135	0.00167	CcSEcCtD
Promethazine—Erythema—Epirubicin—pancreatic cancer	0.000131	0.00163	CcSEcCtD
Promethazine—Feeling abnormal—Docetaxel—pancreatic cancer	0.000131	0.00162	CcSEcCtD
Promethazine—Tinnitus—Doxorubicin—pancreatic cancer	0.00013	0.00161	CcSEcCtD
Promethazine—Tension—Epirubicin—pancreatic cancer	0.000129	0.00159	CcSEcCtD
Promethazine—Nervousness—Epirubicin—pancreatic cancer	0.000127	0.00158	CcSEcCtD
Promethazine—Muscle spasms—Epirubicin—pancreatic cancer	0.000126	0.00156	CcSEcCtD
Promethazine—Arrhythmia—Doxorubicin—pancreatic cancer	0.000124	0.00154	CcSEcCtD
Promethazine—Vision blurred—Epirubicin—pancreatic cancer	0.000124	0.00153	CcSEcCtD
Promethazine—Erythema—Doxorubicin—pancreatic cancer	0.000121	0.0015	CcSEcCtD
Promethazine—Agitation—Epirubicin—pancreatic cancer	0.00012	0.00149	CcSEcCtD
Promethazine—Tension—Doxorubicin—pancreatic cancer	0.000119	0.00148	CcSEcCtD
Promethazine—Nervousness—Doxorubicin—pancreatic cancer	0.000118	0.00146	CcSEcCtD
Promethazine—Syncope—Epirubicin—pancreatic cancer	0.000118	0.00146	CcSEcCtD
Promethazine—Leukopenia—Epirubicin—pancreatic cancer	0.000117	0.00145	CcSEcCtD
Promethazine—Muscle spasms—Doxorubicin—pancreatic cancer	0.000117	0.00145	CcSEcCtD
Promethazine—Palpitations—Epirubicin—pancreatic cancer	0.000116	0.00144	CcSEcCtD
Promethazine—Loss of consciousness—Epirubicin—pancreatic cancer	0.000115	0.00143	CcSEcCtD
Promethazine—Vision blurred—Doxorubicin—pancreatic cancer	0.000114	0.00142	CcSEcCtD
Promethazine—Asthenia—Docetaxel—pancreatic cancer	0.000114	0.00141	CcSEcCtD
Promethazine—Convulsion—Epirubicin—pancreatic cancer	0.000114	0.00141	CcSEcCtD
Promethazine—Pruritus—Docetaxel—pancreatic cancer	0.000112	0.00139	CcSEcCtD
Promethazine—Agitation—Doxorubicin—pancreatic cancer	0.000111	0.00138	CcSEcCtD
Promethazine—Anxiety—Epirubicin—pancreatic cancer	0.000111	0.00138	CcSEcCtD
Promethazine—Dry mouth—Epirubicin—pancreatic cancer	0.000109	0.00135	CcSEcCtD
Promethazine—Syncope—Doxorubicin—pancreatic cancer	0.000109	0.00135	CcSEcCtD
Promethazine—Leukopenia—Doxorubicin—pancreatic cancer	0.000109	0.00135	CcSEcCtD
Promethazine—Diarrhoea—Docetaxel—pancreatic cancer	0.000109	0.00135	CcSEcCtD
Promethazine—Confusional state—Epirubicin—pancreatic cancer	0.000108	0.00134	CcSEcCtD
Promethazine—Palpitations—Doxorubicin—pancreatic cancer	0.000107	0.00133	CcSEcCtD
Promethazine—Anaphylactic shock—Epirubicin—pancreatic cancer	0.000107	0.00133	CcSEcCtD
Promethazine—Oedema—Epirubicin—pancreatic cancer	0.000107	0.00133	CcSEcCtD
Promethazine—Loss of consciousness—Doxorubicin—pancreatic cancer	0.000107	0.00132	CcSEcCtD
Promethazine—Shock—Epirubicin—pancreatic cancer	0.000105	0.0013	CcSEcCtD
Promethazine—Convulsion—Doxorubicin—pancreatic cancer	0.000105	0.0013	CcSEcCtD
Promethazine—Dizziness—Docetaxel—pancreatic cancer	0.000105	0.0013	CcSEcCtD
Promethazine—Thrombocytopenia—Epirubicin—pancreatic cancer	0.000105	0.0013	CcSEcCtD
Promethazine—Tachycardia—Epirubicin—pancreatic cancer	0.000104	0.00129	CcSEcCtD
Promethazine—Anxiety—Doxorubicin—pancreatic cancer	0.000103	0.00128	CcSEcCtD
Promethazine—Dry mouth—Doxorubicin—pancreatic cancer	0.000101	0.00125	CcSEcCtD
Promethazine—Rash—Docetaxel—pancreatic cancer	0.0001	0.00124	CcSEcCtD
Promethazine—Hypotension—Epirubicin—pancreatic cancer	0.0001	0.00124	CcSEcCtD
Promethazine—Dermatitis—Docetaxel—pancreatic cancer	9.99e-05	0.00124	CcSEcCtD
Promethazine—Confusional state—Doxorubicin—pancreatic cancer	9.98e-05	0.00124	CcSEcCtD
Promethazine—Headache—Docetaxel—pancreatic cancer	9.94e-05	0.00123	CcSEcCtD
Promethazine—Anaphylactic shock—Doxorubicin—pancreatic cancer	9.9e-05	0.00123	CcSEcCtD
Promethazine—Oedema—Doxorubicin—pancreatic cancer	9.9e-05	0.00123	CcSEcCtD
Promethazine—Shock—Doxorubicin—pancreatic cancer	9.74e-05	0.00121	CcSEcCtD
Promethazine—Thrombocytopenia—Doxorubicin—pancreatic cancer	9.69e-05	0.0012	CcSEcCtD
Promethazine—Insomnia—Epirubicin—pancreatic cancer	9.68e-05	0.0012	CcSEcCtD
Promethazine—Tachycardia—Doxorubicin—pancreatic cancer	9.66e-05	0.0012	CcSEcCtD
Promethazine—Somnolence—Epirubicin—pancreatic cancer	9.51e-05	0.00118	CcSEcCtD
Promethazine—Dyspepsia—Epirubicin—pancreatic cancer	9.42e-05	0.00117	CcSEcCtD
Promethazine—Decreased appetite—Epirubicin—pancreatic cancer	9.3e-05	0.00115	CcSEcCtD
Promethazine—Hypotension—Doxorubicin—pancreatic cancer	9.25e-05	0.00115	CcSEcCtD
Promethazine—Fatigue—Epirubicin—pancreatic cancer	9.22e-05	0.00114	CcSEcCtD
Promethazine—Pain—Epirubicin—pancreatic cancer	9.15e-05	0.00113	CcSEcCtD
Promethazine—Constipation—Epirubicin—pancreatic cancer	9.15e-05	0.00113	CcSEcCtD
Promethazine—Insomnia—Doxorubicin—pancreatic cancer	8.95e-05	0.00111	CcSEcCtD
Promethazine—Feeling abnormal—Epirubicin—pancreatic cancer	8.82e-05	0.00109	CcSEcCtD
Promethazine—Somnolence—Doxorubicin—pancreatic cancer	8.8e-05	0.00109	CcSEcCtD
Promethazine—Dyspepsia—Doxorubicin—pancreatic cancer	8.71e-05	0.00108	CcSEcCtD
Promethazine—Decreased appetite—Doxorubicin—pancreatic cancer	8.61e-05	0.00107	CcSEcCtD
Promethazine—Fatigue—Doxorubicin—pancreatic cancer	8.54e-05	0.00106	CcSEcCtD
Promethazine—Constipation—Doxorubicin—pancreatic cancer	8.47e-05	0.00105	CcSEcCtD
Promethazine—Pain—Doxorubicin—pancreatic cancer	8.47e-05	0.00105	CcSEcCtD
Promethazine—Feeling abnormal—Doxorubicin—pancreatic cancer	8.16e-05	0.00101	CcSEcCtD
Promethazine—Asthenia—Epirubicin—pancreatic cancer	7.68e-05	0.000952	CcSEcCtD
Promethazine—Pruritus—Epirubicin—pancreatic cancer	7.57e-05	0.000938	CcSEcCtD
Promethazine—Diarrhoea—Epirubicin—pancreatic cancer	7.32e-05	0.000907	CcSEcCtD
Promethazine—Asthenia—Doxorubicin—pancreatic cancer	7.1e-05	0.00088	CcSEcCtD
Promethazine—Dizziness—Epirubicin—pancreatic cancer	7.08e-05	0.000877	CcSEcCtD
Promethazine—Pruritus—Doxorubicin—pancreatic cancer	7e-05	0.000868	CcSEcCtD
Promethazine—Diarrhoea—Doxorubicin—pancreatic cancer	6.77e-05	0.00084	CcSEcCtD
Promethazine—Rash—Epirubicin—pancreatic cancer	6.75e-05	0.000836	CcSEcCtD
Promethazine—Dermatitis—Epirubicin—pancreatic cancer	6.74e-05	0.000835	CcSEcCtD
Promethazine—Headache—Epirubicin—pancreatic cancer	6.7e-05	0.000831	CcSEcCtD
Promethazine—Dizziness—Doxorubicin—pancreatic cancer	6.55e-05	0.000811	CcSEcCtD
Promethazine—Rash—Doxorubicin—pancreatic cancer	6.24e-05	0.000774	CcSEcCtD
Promethazine—Dermatitis—Doxorubicin—pancreatic cancer	6.24e-05	0.000773	CcSEcCtD
Promethazine—Headache—Doxorubicin—pancreatic cancer	6.2e-05	0.000769	CcSEcCtD
Promethazine—CHRM1—Signaling Pathways—CTNNB1—pancreatic cancer	3.59e-06	2.94e-05	CbGpPWpGaD
Promethazine—CYP2B6—Metabolism—PTEN—pancreatic cancer	3.59e-06	2.94e-05	CbGpPWpGaD
Promethazine—CHRM2—Signaling Pathways—CCND1—pancreatic cancer	3.58e-06	2.93e-05	CbGpPWpGaD
Promethazine—CHRM3—Signaling Pathways—CTNNB1—pancreatic cancer	3.58e-06	2.93e-05	CbGpPWpGaD
Promethazine—DRD2—Signaling Pathways—PTEN—pancreatic cancer	3.58e-06	2.93e-05	CbGpPWpGaD
Promethazine—ADRA1A—Signaling Pathways—CCND1—pancreatic cancer	3.57e-06	2.92e-05	CbGpPWpGaD
Promethazine—CALM2—Immune System—EGFR—pancreatic cancer	3.55e-06	2.91e-05	CbGpPWpGaD
Promethazine—CALM1—Immune System—EGFR—pancreatic cancer	3.55e-06	2.91e-05	CbGpPWpGaD
Promethazine—CHRM2—Signaling Pathways—CTNNB1—pancreatic cancer	3.55e-06	2.9e-05	CbGpPWpGaD
Promethazine—CHRM4—Signaling Pathways—TP53—pancreatic cancer	3.54e-06	2.9e-05	CbGpPWpGaD
Promethazine—HTR2A—Signaling Pathways—MMP9—pancreatic cancer	3.54e-06	2.9e-05	CbGpPWpGaD
Promethazine—ADRA1A—Signaling Pathways—CTNNB1—pancreatic cancer	3.54e-06	2.89e-05	CbGpPWpGaD
Promethazine—HRH1—Signaling Pathways—MMP9—pancreatic cancer	3.53e-06	2.89e-05	CbGpPWpGaD
Promethazine—CHRM1—Signaling Pathways—MMP9—pancreatic cancer	3.52e-06	2.88e-05	CbGpPWpGaD
Promethazine—HTR2A—Signaling Pathways—PTEN—pancreatic cancer	3.52e-06	2.88e-05	CbGpPWpGaD
Promethazine—ABCB1—Metabolism—PIK3CD—pancreatic cancer	3.52e-06	2.88e-05	CbGpPWpGaD
Promethazine—HRH1—Signaling Pathways—PTEN—pancreatic cancer	3.51e-06	2.87e-05	CbGpPWpGaD
Promethazine—CHRM3—Signaling Pathways—MMP9—pancreatic cancer	3.51e-06	2.87e-05	CbGpPWpGaD
Promethazine—CHRM5—Signaling Pathways—PIK3CA—pancreatic cancer	3.51e-06	2.87e-05	CbGpPWpGaD
Promethazine—CHRM1—Signaling Pathways—PTEN—pancreatic cancer	3.5e-06	2.86e-05	CbGpPWpGaD
Promethazine—CALM3—Metabolism—PTEN—pancreatic cancer	3.49e-06	2.86e-05	CbGpPWpGaD
Promethazine—DRD2—Signaling by GPCR—AKT1—pancreatic cancer	3.49e-06	2.85e-05	CbGpPWpGaD
Promethazine—CHRM3—Signaling Pathways—PTEN—pancreatic cancer	3.49e-06	2.85e-05	CbGpPWpGaD
Promethazine—CALM3—Signaling by GPCR—PIK3CA—pancreatic cancer	3.49e-06	2.85e-05	CbGpPWpGaD
Promethazine—CHRM2—Signaling Pathways—MMP9—pancreatic cancer	3.48e-06	2.84e-05	CbGpPWpGaD
Promethazine—CALM3—Immune System—KRAS—pancreatic cancer	3.47e-06	2.84e-05	CbGpPWpGaD
Promethazine—CALM3—Disease—MYC—pancreatic cancer	3.47e-06	2.84e-05	CbGpPWpGaD
Promethazine—ADRA1A—Signaling Pathways—MMP9—pancreatic cancer	3.47e-06	2.83e-05	CbGpPWpGaD
Promethazine—CALM3—Disease—TGFB1—pancreatic cancer	3.46e-06	2.83e-05	CbGpPWpGaD
Promethazine—CHRM2—Signaling Pathways—PTEN—pancreatic cancer	3.46e-06	2.83e-05	CbGpPWpGaD
Promethazine—ADRA1A—Signaling Pathways—PTEN—pancreatic cancer	3.45e-06	2.82e-05	CbGpPWpGaD
Promethazine—HTR2A—Signaling by GPCR—AKT1—pancreatic cancer	3.43e-06	2.81e-05	CbGpPWpGaD
Promethazine—HRH1—Signaling by GPCR—AKT1—pancreatic cancer	3.43e-06	2.8e-05	CbGpPWpGaD
Promethazine—CHRM1—Signaling by GPCR—AKT1—pancreatic cancer	3.42e-06	2.79e-05	CbGpPWpGaD
Promethazine—CHRM3—Signaling by GPCR—AKT1—pancreatic cancer	3.4e-06	2.78e-05	CbGpPWpGaD
Promethazine—CHRM5—Signaling Pathways—TP53—pancreatic cancer	3.39e-06	2.77e-05	CbGpPWpGaD
Promethazine—CALM3—Disease—EGFR—pancreatic cancer	3.39e-06	2.77e-05	CbGpPWpGaD
Promethazine—CHRM4—Signaling Pathways—HRAS—pancreatic cancer	3.39e-06	2.77e-05	CbGpPWpGaD
Promethazine—CALM3—Signaling Pathways—PIK3CB—pancreatic cancer	3.38e-06	2.76e-05	CbGpPWpGaD
Promethazine—CALM2—Metabolism—PTEN—pancreatic cancer	3.38e-06	2.76e-05	CbGpPWpGaD
Promethazine—CALM1—Metabolism—PTEN—pancreatic cancer	3.38e-06	2.76e-05	CbGpPWpGaD
Promethazine—CALM2—Signaling by GPCR—PIK3CA—pancreatic cancer	3.38e-06	2.76e-05	CbGpPWpGaD
Promethazine—CALM1—Signaling by GPCR—PIK3CA—pancreatic cancer	3.38e-06	2.76e-05	CbGpPWpGaD
Promethazine—CHRM2—Signaling by GPCR—AKT1—pancreatic cancer	3.37e-06	2.76e-05	CbGpPWpGaD
Promethazine—ADRA1A—Signaling by GPCR—AKT1—pancreatic cancer	3.36e-06	2.75e-05	CbGpPWpGaD
Promethazine—CALM2—Immune System—KRAS—pancreatic cancer	3.36e-06	2.74e-05	CbGpPWpGaD
Promethazine—CALM1—Immune System—KRAS—pancreatic cancer	3.36e-06	2.74e-05	CbGpPWpGaD
Promethazine—CALM1—Disease—MYC—pancreatic cancer	3.35e-06	2.74e-05	CbGpPWpGaD
Promethazine—CALM2—Disease—MYC—pancreatic cancer	3.35e-06	2.74e-05	CbGpPWpGaD
Promethazine—CALM2—Disease—TGFB1—pancreatic cancer	3.35e-06	2.74e-05	CbGpPWpGaD
Promethazine—CALM1—Disease—TGFB1—pancreatic cancer	3.35e-06	2.74e-05	CbGpPWpGaD
Promethazine—DRD2—Signaling Pathways—SRC—pancreatic cancer	3.32e-06	2.71e-05	CbGpPWpGaD
Promethazine—CYP2D6—Metabolism—PIK3CD—pancreatic cancer	3.31e-06	2.71e-05	CbGpPWpGaD
Promethazine—CYP2C9—Metabolism—PIK3CD—pancreatic cancer	3.28e-06	2.69e-05	CbGpPWpGaD
Promethazine—CALM1—Disease—EGFR—pancreatic cancer	3.28e-06	2.68e-05	CbGpPWpGaD
Promethazine—CALM2—Disease—EGFR—pancreatic cancer	3.28e-06	2.68e-05	CbGpPWpGaD
Promethazine—CALM2—Signaling Pathways—PIK3CB—pancreatic cancer	3.27e-06	2.67e-05	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—PIK3CB—pancreatic cancer	3.27e-06	2.67e-05	CbGpPWpGaD
Promethazine—HTR2A—Signaling Pathways—SRC—pancreatic cancer	3.26e-06	2.67e-05	CbGpPWpGaD
Promethazine—HRH1—Signaling Pathways—SRC—pancreatic cancer	3.26e-06	2.66e-05	CbGpPWpGaD
Promethazine—CALM3—Signaling Pathways—CXCL8—pancreatic cancer	3.25e-06	2.66e-05	CbGpPWpGaD
Promethazine—CHRM1—Signaling Pathways—SRC—pancreatic cancer	3.25e-06	2.65e-05	CbGpPWpGaD
Promethazine—CHRM5—Signaling Pathways—HRAS—pancreatic cancer	3.25e-06	2.65e-05	CbGpPWpGaD
Promethazine—CHRM3—Signaling Pathways—SRC—pancreatic cancer	3.24e-06	2.65e-05	CbGpPWpGaD
Promethazine—DRD2—Signaling Pathways—VEGFA—pancreatic cancer	3.23e-06	2.64e-05	CbGpPWpGaD
Promethazine—CALM3—Signaling by GPCR—HRAS—pancreatic cancer	3.23e-06	2.64e-05	CbGpPWpGaD
Promethazine—CHRM2—Signaling Pathways—SRC—pancreatic cancer	3.21e-06	2.62e-05	CbGpPWpGaD
Promethazine—CALM3—Disease—KRAS—pancreatic cancer	3.2e-06	2.62e-05	CbGpPWpGaD
Promethazine—DRD2—Signaling Pathways—STAT3—pancreatic cancer	3.2e-06	2.62e-05	CbGpPWpGaD
Promethazine—ADRA1A—Signaling Pathways—SRC—pancreatic cancer	3.2e-06	2.61e-05	CbGpPWpGaD
Promethazine—DRD2—Signaling Pathways—NRAS—pancreatic cancer	3.19e-06	2.61e-05	CbGpPWpGaD
Promethazine—CALM3—Immune System—PIK3CA—pancreatic cancer	3.19e-06	2.61e-05	CbGpPWpGaD
Promethazine—HTR2A—Signaling Pathways—VEGFA—pancreatic cancer	3.18e-06	2.6e-05	CbGpPWpGaD
Promethazine—HRH1—Signaling Pathways—VEGFA—pancreatic cancer	3.17e-06	2.59e-05	CbGpPWpGaD
Promethazine—CHRM1—Signaling Pathways—VEGFA—pancreatic cancer	3.16e-06	2.59e-05	CbGpPWpGaD
Promethazine—CHRM3—Signaling Pathways—VEGFA—pancreatic cancer	3.15e-06	2.58e-05	CbGpPWpGaD
Promethazine—HTR2A—Signaling Pathways—STAT3—pancreatic cancer	3.15e-06	2.57e-05	CbGpPWpGaD
Promethazine—CALM2—Signaling Pathways—CXCL8—pancreatic cancer	3.14e-06	2.57e-05	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—CXCL8—pancreatic cancer	3.14e-06	2.57e-05	CbGpPWpGaD
Promethazine—HRH1—Signaling Pathways—STAT3—pancreatic cancer	3.14e-06	2.57e-05	CbGpPWpGaD
Promethazine—HTR2A—Signaling Pathways—NRAS—pancreatic cancer	3.14e-06	2.57e-05	CbGpPWpGaD
Promethazine—HRH1—Signaling Pathways—NRAS—pancreatic cancer	3.13e-06	2.56e-05	CbGpPWpGaD
Promethazine—CHRM1—Signaling Pathways—STAT3—pancreatic cancer	3.13e-06	2.56e-05	CbGpPWpGaD
Promethazine—CHRM1—Signaling Pathways—NRAS—pancreatic cancer	3.12e-06	2.55e-05	CbGpPWpGaD
Promethazine—CALM2—Signaling by GPCR—HRAS—pancreatic cancer	3.12e-06	2.55e-05	CbGpPWpGaD
Promethazine—CALM1—Signaling by GPCR—HRAS—pancreatic cancer	3.12e-06	2.55e-05	CbGpPWpGaD
Promethazine—CHRM2—Signaling Pathways—VEGFA—pancreatic cancer	3.12e-06	2.55e-05	CbGpPWpGaD
Promethazine—CHRM3—Signaling Pathways—STAT3—pancreatic cancer	3.12e-06	2.55e-05	CbGpPWpGaD
Promethazine—CHRM3—Signaling Pathways—NRAS—pancreatic cancer	3.11e-06	2.55e-05	CbGpPWpGaD
Promethazine—ADRA1A—Signaling Pathways—VEGFA—pancreatic cancer	3.11e-06	2.55e-05	CbGpPWpGaD
Promethazine—CALM3—Signaling Pathways—CASP3—pancreatic cancer	3.11e-06	2.54e-05	CbGpPWpGaD
Promethazine—CALM2—Disease—KRAS—pancreatic cancer	3.1e-06	2.53e-05	CbGpPWpGaD
Promethazine—CALM1—Disease—KRAS—pancreatic cancer	3.1e-06	2.53e-05	CbGpPWpGaD
Promethazine—CHRM2—Signaling Pathways—STAT3—pancreatic cancer	3.09e-06	2.53e-05	CbGpPWpGaD
Promethazine—CALM1—Immune System—PIK3CA—pancreatic cancer	3.08e-06	2.52e-05	CbGpPWpGaD
Promethazine—CALM2—Immune System—PIK3CA—pancreatic cancer	3.08e-06	2.52e-05	CbGpPWpGaD
Promethazine—CHRM2—Signaling Pathways—NRAS—pancreatic cancer	3.08e-06	2.52e-05	CbGpPWpGaD
Promethazine—ADRA1A—Signaling Pathways—STAT3—pancreatic cancer	3.08e-06	2.52e-05	CbGpPWpGaD
Promethazine—ADRA1A—Signaling Pathways—NRAS—pancreatic cancer	3.07e-06	2.51e-05	CbGpPWpGaD
Promethazine—ABCB1—Metabolism—PIK3CB—pancreatic cancer	3.06e-06	2.51e-05	CbGpPWpGaD
Promethazine—ABCB1—Metabolism—PTGS2—pancreatic cancer	3.04e-06	2.48e-05	CbGpPWpGaD
Promethazine—CALM3—Signaling Pathways—CCND1—pancreatic cancer	3.03e-06	2.48e-05	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—CASP3—pancreatic cancer	3.01e-06	2.46e-05	CbGpPWpGaD
Promethazine—CALM2—Signaling Pathways—CASP3—pancreatic cancer	3.01e-06	2.46e-05	CbGpPWpGaD
Promethazine—CALM3—Signaling Pathways—CTNNB1—pancreatic cancer	3e-06	2.45e-05	CbGpPWpGaD
Promethazine—CHRM4—Signaling Pathways—AKT1—pancreatic cancer	2.99e-06	2.45e-05	CbGpPWpGaD
Promethazine—DRD2—Signaling Pathways—MYC—pancreatic cancer	2.97e-06	2.43e-05	CbGpPWpGaD
Promethazine—DRD2—Signaling Pathways—TGFB1—pancreatic cancer	2.97e-06	2.42e-05	CbGpPWpGaD
Promethazine—CALM3—Immune System—HRAS—pancreatic cancer	2.95e-06	2.41e-05	CbGpPWpGaD
Promethazine—CHRM3—Metabolism—PIK3CA—pancreatic cancer	2.94e-06	2.41e-05	CbGpPWpGaD
Promethazine—CALM3—Disease—PIK3CA—pancreatic cancer	2.94e-06	2.41e-05	CbGpPWpGaD
Promethazine—CALM3—Signaling Pathways—MMP9—pancreatic cancer	2.94e-06	2.4e-05	CbGpPWpGaD
Promethazine—CALM2—Signaling Pathways—CCND1—pancreatic cancer	2.93e-06	2.39e-05	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—CCND1—pancreatic cancer	2.93e-06	2.39e-05	CbGpPWpGaD
Promethazine—HTR2A—Signaling Pathways—MYC—pancreatic cancer	2.93e-06	2.39e-05	CbGpPWpGaD
Promethazine—CALM3—Signaling Pathways—PTEN—pancreatic cancer	2.92e-06	2.39e-05	CbGpPWpGaD
Promethazine—HRH1—Signaling Pathways—MYC—pancreatic cancer	2.92e-06	2.39e-05	CbGpPWpGaD
Promethazine—HTR2A—Signaling Pathways—TGFB1—pancreatic cancer	2.92e-06	2.39e-05	CbGpPWpGaD
Promethazine—HRH1—Signaling Pathways—TGFB1—pancreatic cancer	2.91e-06	2.38e-05	CbGpPWpGaD
Promethazine—CHRM1—Signaling Pathways—MYC—pancreatic cancer	2.91e-06	2.38e-05	CbGpPWpGaD
Promethazine—DRD2—Signaling Pathways—EGFR—pancreatic cancer	2.91e-06	2.38e-05	CbGpPWpGaD
Promethazine—CHRM1—Signaling Pathways—TGFB1—pancreatic cancer	2.9e-06	2.37e-05	CbGpPWpGaD
Promethazine—CHRM3—Signaling Pathways—MYC—pancreatic cancer	2.9e-06	2.37e-05	CbGpPWpGaD
Promethazine—CALM2—Signaling Pathways—CTNNB1—pancreatic cancer	2.9e-06	2.37e-05	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—CTNNB1—pancreatic cancer	2.9e-06	2.37e-05	CbGpPWpGaD
Promethazine—CHRM3—Signaling Pathways—TGFB1—pancreatic cancer	2.89e-06	2.37e-05	CbGpPWpGaD
Promethazine—CYP2D6—Metabolism—PIK3CB—pancreatic cancer	2.89e-06	2.36e-05	CbGpPWpGaD
Promethazine—CHRM2—Signaling Pathways—MYC—pancreatic cancer	2.87e-06	2.35e-05	CbGpPWpGaD
Promethazine—CHRM5—Signaling Pathways—AKT1—pancreatic cancer	2.87e-06	2.34e-05	CbGpPWpGaD
Promethazine—CHRM2—Signaling Pathways—TGFB1—pancreatic cancer	2.87e-06	2.34e-05	CbGpPWpGaD
Promethazine—ADRA1A—Signaling Pathways—MYC—pancreatic cancer	2.86e-06	2.34e-05	CbGpPWpGaD
Promethazine—CYP2C9—Metabolism—PIK3CB—pancreatic cancer	2.86e-06	2.34e-05	CbGpPWpGaD
Promethazine—CYP2D6—Metabolism—PTGS2—pancreatic cancer	2.86e-06	2.34e-05	CbGpPWpGaD
Promethazine—HTR2A—Signaling Pathways—EGFR—pancreatic cancer	2.86e-06	2.34e-05	CbGpPWpGaD
Promethazine—ADRA1A—Signaling Pathways—TGFB1—pancreatic cancer	2.86e-06	2.34e-05	CbGpPWpGaD
Promethazine—HRH1—Signaling Pathways—EGFR—pancreatic cancer	2.85e-06	2.33e-05	CbGpPWpGaD
Promethazine—CALM1—Immune System—HRAS—pancreatic cancer	2.85e-06	2.33e-05	CbGpPWpGaD
Promethazine—CALM2—Immune System—HRAS—pancreatic cancer	2.85e-06	2.33e-05	CbGpPWpGaD
Promethazine—CALM3—Signaling by GPCR—AKT1—pancreatic cancer	2.85e-06	2.33e-05	CbGpPWpGaD
Promethazine—CALM1—Disease—PIK3CA—pancreatic cancer	2.85e-06	2.33e-05	CbGpPWpGaD
Promethazine—CALM2—Disease—PIK3CA—pancreatic cancer	2.85e-06	2.33e-05	CbGpPWpGaD
Promethazine—CHRM1—Signaling Pathways—EGFR—pancreatic cancer	2.85e-06	2.33e-05	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—MMP9—pancreatic cancer	2.84e-06	2.32e-05	CbGpPWpGaD
Promethazine—CALM2—Signaling Pathways—MMP9—pancreatic cancer	2.84e-06	2.32e-05	CbGpPWpGaD
Promethazine—CYP2C9—Metabolism—PTGS2—pancreatic cancer	2.84e-06	2.32e-05	CbGpPWpGaD
Promethazine—CHRM3—Signaling Pathways—EGFR—pancreatic cancer	2.84e-06	2.32e-05	CbGpPWpGaD
Promethazine—CALM2—Signaling Pathways—PTEN—pancreatic cancer	2.83e-06	2.31e-05	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—PTEN—pancreatic cancer	2.83e-06	2.31e-05	CbGpPWpGaD
Promethazine—CHRM2—Signaling Pathways—EGFR—pancreatic cancer	2.81e-06	2.3e-05	CbGpPWpGaD
Promethazine—ADRA1A—Signaling Pathways—EGFR—pancreatic cancer	2.8e-06	2.29e-05	CbGpPWpGaD
Promethazine—CALM1—Signaling by GPCR—AKT1—pancreatic cancer	2.76e-06	2.25e-05	CbGpPWpGaD
Promethazine—CALM2—Signaling by GPCR—AKT1—pancreatic cancer	2.76e-06	2.25e-05	CbGpPWpGaD
Promethazine—DRD2—Signaling Pathways—KRAS—pancreatic cancer	2.75e-06	2.25e-05	CbGpPWpGaD
Promethazine—CALM3—Disease—HRAS—pancreatic cancer	2.72e-06	2.23e-05	CbGpPWpGaD
Promethazine—CALM3—Signaling Pathways—SRC—pancreatic cancer	2.71e-06	2.22e-05	CbGpPWpGaD
Promethazine—HTR2A—Signaling Pathways—KRAS—pancreatic cancer	2.7e-06	2.21e-05	CbGpPWpGaD
Promethazine—HRH1—Signaling Pathways—KRAS—pancreatic cancer	2.7e-06	2.21e-05	CbGpPWpGaD
Promethazine—CHRM1—Signaling Pathways—KRAS—pancreatic cancer	2.69e-06	2.2e-05	CbGpPWpGaD
Promethazine—CHRM3—Signaling Pathways—KRAS—pancreatic cancer	2.68e-06	2.19e-05	CbGpPWpGaD
Promethazine—CHRM2—Signaling Pathways—KRAS—pancreatic cancer	2.65e-06	2.17e-05	CbGpPWpGaD
Promethazine—ABCB1—Metabolism—PTEN—pancreatic cancer	2.65e-06	2.17e-05	CbGpPWpGaD
Promethazine—ADRA1A—Signaling Pathways—KRAS—pancreatic cancer	2.65e-06	2.16e-05	CbGpPWpGaD
Promethazine—CALM3—Signaling Pathways—VEGFA—pancreatic cancer	2.64e-06	2.16e-05	CbGpPWpGaD
Promethazine—CALM2—Disease—HRAS—pancreatic cancer	2.63e-06	2.15e-05	CbGpPWpGaD
Promethazine—CALM1—Disease—HRAS—pancreatic cancer	2.63e-06	2.15e-05	CbGpPWpGaD
Promethazine—CALM2—Signaling Pathways—SRC—pancreatic cancer	2.62e-06	2.14e-05	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—SRC—pancreatic cancer	2.62e-06	2.14e-05	CbGpPWpGaD
Promethazine—CALM3—Signaling Pathways—STAT3—pancreatic cancer	2.61e-06	2.14e-05	CbGpPWpGaD
Promethazine—CALM3—Signaling Pathways—NRAS—pancreatic cancer	2.61e-06	2.13e-05	CbGpPWpGaD
Promethazine—CALM3—Immune System—AKT1—pancreatic cancer	2.6e-06	2.13e-05	CbGpPWpGaD
Promethazine—CALM2—Signaling Pathways—VEGFA—pancreatic cancer	2.55e-06	2.09e-05	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—VEGFA—pancreatic cancer	2.55e-06	2.09e-05	CbGpPWpGaD
Promethazine—CYP2B6—Metabolism—PIK3CA—pancreatic cancer	2.53e-06	2.07e-05	CbGpPWpGaD
Promethazine—CALM2—Signaling Pathways—STAT3—pancreatic cancer	2.53e-06	2.07e-05	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—STAT3—pancreatic cancer	2.53e-06	2.07e-05	CbGpPWpGaD
Promethazine—DRD2—Signaling Pathways—PIK3CA—pancreatic cancer	2.52e-06	2.06e-05	CbGpPWpGaD
Promethazine—CALM2—Signaling Pathways—NRAS—pancreatic cancer	2.52e-06	2.06e-05	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—NRAS—pancreatic cancer	2.52e-06	2.06e-05	CbGpPWpGaD
Promethazine—CALM1—Immune System—AKT1—pancreatic cancer	2.52e-06	2.06e-05	CbGpPWpGaD
Promethazine—CALM2—Immune System—AKT1—pancreatic cancer	2.52e-06	2.06e-05	CbGpPWpGaD
Promethazine—CYP2D6—Metabolism—PTEN—pancreatic cancer	2.5e-06	2.04e-05	CbGpPWpGaD
Promethazine—HTR2A—Signaling Pathways—PIK3CA—pancreatic cancer	2.48e-06	2.03e-05	CbGpPWpGaD
Promethazine—HRH1—Signaling Pathways—PIK3CA—pancreatic cancer	2.48e-06	2.03e-05	CbGpPWpGaD
Promethazine—CYP2C9—Metabolism—PTEN—pancreatic cancer	2.47e-06	2.02e-05	CbGpPWpGaD
Promethazine—CHRM1—Signaling Pathways—PIK3CA—pancreatic cancer	2.47e-06	2.02e-05	CbGpPWpGaD
Promethazine—CALM3—Metabolism—PIK3CA—pancreatic cancer	2.47e-06	2.02e-05	CbGpPWpGaD
Promethazine—CHRM3—Signaling Pathways—PIK3CA—pancreatic cancer	2.46e-06	2.01e-05	CbGpPWpGaD
Promethazine—DRD2—Signaling Pathways—TP53—pancreatic cancer	2.44e-06	2e-05	CbGpPWpGaD
Promethazine—CHRM2—Signaling Pathways—PIK3CA—pancreatic cancer	2.44e-06	1.99e-05	CbGpPWpGaD
Promethazine—ADRA1A—Signaling Pathways—PIK3CA—pancreatic cancer	2.43e-06	1.99e-05	CbGpPWpGaD
Promethazine—CALM3—Signaling Pathways—MYC—pancreatic cancer	2.43e-06	1.99e-05	CbGpPWpGaD
Promethazine—CALM3—Signaling Pathways—TGFB1—pancreatic cancer	2.42e-06	1.98e-05	CbGpPWpGaD
Promethazine—CHRM3—Metabolism—AKT1—pancreatic cancer	2.41e-06	1.97e-05	CbGpPWpGaD
Promethazine—CALM3—Disease—AKT1—pancreatic cancer	2.4e-06	1.97e-05	CbGpPWpGaD
Promethazine—HTR2A—Signaling Pathways—TP53—pancreatic cancer	2.4e-06	1.96e-05	CbGpPWpGaD
Promethazine—HRH1—Signaling Pathways—TP53—pancreatic cancer	2.4e-06	1.96e-05	CbGpPWpGaD
Promethazine—CHRM1—Signaling Pathways—TP53—pancreatic cancer	2.39e-06	1.95e-05	CbGpPWpGaD
Promethazine—CALM1—Metabolism—PIK3CA—pancreatic cancer	2.38e-06	1.95e-05	CbGpPWpGaD
Promethazine—CALM2—Metabolism—PIK3CA—pancreatic cancer	2.38e-06	1.95e-05	CbGpPWpGaD
Promethazine—CHRM3—Signaling Pathways—TP53—pancreatic cancer	2.38e-06	1.95e-05	CbGpPWpGaD
Promethazine—CALM3—Signaling Pathways—EGFR—pancreatic cancer	2.38e-06	1.94e-05	CbGpPWpGaD
Promethazine—CHRM2—Signaling Pathways—TP53—pancreatic cancer	2.36e-06	1.93e-05	CbGpPWpGaD
Promethazine—ADRA1A—Signaling Pathways—TP53—pancreatic cancer	2.35e-06	1.92e-05	CbGpPWpGaD
Promethazine—CALM2—Signaling Pathways—MYC—pancreatic cancer	2.35e-06	1.92e-05	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—MYC—pancreatic cancer	2.35e-06	1.92e-05	CbGpPWpGaD
Promethazine—CALM2—Signaling Pathways—TGFB1—pancreatic cancer	2.34e-06	1.92e-05	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—TGFB1—pancreatic cancer	2.34e-06	1.92e-05	CbGpPWpGaD
Promethazine—DRD2—Signaling Pathways—HRAS—pancreatic cancer	2.33e-06	1.91e-05	CbGpPWpGaD
Promethazine—CALM2—Disease—AKT1—pancreatic cancer	2.33e-06	1.9e-05	CbGpPWpGaD
Promethazine—CALM1—Disease—AKT1—pancreatic cancer	2.33e-06	1.9e-05	CbGpPWpGaD
Promethazine—CALM2—Signaling Pathways—EGFR—pancreatic cancer	2.3e-06	1.88e-05	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—EGFR—pancreatic cancer	2.3e-06	1.88e-05	CbGpPWpGaD
Promethazine—HTR2A—Signaling Pathways—HRAS—pancreatic cancer	2.3e-06	1.88e-05	CbGpPWpGaD
Promethazine—HRH1—Signaling Pathways—HRAS—pancreatic cancer	2.29e-06	1.87e-05	CbGpPWpGaD
Promethazine—CHRM1—Signaling Pathways—HRAS—pancreatic cancer	2.29e-06	1.87e-05	CbGpPWpGaD
Promethazine—CHRM3—Signaling Pathways—HRAS—pancreatic cancer	2.28e-06	1.86e-05	CbGpPWpGaD
Promethazine—CHRM2—Signaling Pathways—HRAS—pancreatic cancer	2.26e-06	1.84e-05	CbGpPWpGaD
Promethazine—ADRA1A—Signaling Pathways—HRAS—pancreatic cancer	2.25e-06	1.84e-05	CbGpPWpGaD
Promethazine—CALM3—Signaling Pathways—KRAS—pancreatic cancer	2.24e-06	1.83e-05	CbGpPWpGaD
Promethazine—CALM2—Signaling Pathways—KRAS—pancreatic cancer	2.17e-06	1.77e-05	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—KRAS—pancreatic cancer	2.17e-06	1.77e-05	CbGpPWpGaD
Promethazine—CYP2B6—Metabolism—AKT1—pancreatic cancer	2.07e-06	1.69e-05	CbGpPWpGaD
Promethazine—DRD2—Signaling Pathways—AKT1—pancreatic cancer	2.06e-06	1.69e-05	CbGpPWpGaD
Promethazine—CALM3—Signaling Pathways—PIK3CA—pancreatic cancer	2.06e-06	1.69e-05	CbGpPWpGaD
Promethazine—HTR2A—Signaling Pathways—AKT1—pancreatic cancer	2.03e-06	1.66e-05	CbGpPWpGaD
Promethazine—HRH1—Signaling Pathways—AKT1—pancreatic cancer	2.02e-06	1.66e-05	CbGpPWpGaD
Promethazine—CHRM1—Signaling Pathways—AKT1—pancreatic cancer	2.02e-06	1.65e-05	CbGpPWpGaD
Promethazine—CALM3—Metabolism—AKT1—pancreatic cancer	2.01e-06	1.65e-05	CbGpPWpGaD
Promethazine—CHRM3—Signaling Pathways—AKT1—pancreatic cancer	2.01e-06	1.64e-05	CbGpPWpGaD
Promethazine—CALM3—Signaling Pathways—TP53—pancreatic cancer	1.99e-06	1.63e-05	CbGpPWpGaD
Promethazine—CALM2—Signaling Pathways—PIK3CA—pancreatic cancer	1.99e-06	1.63e-05	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—PIK3CA—pancreatic cancer	1.99e-06	1.63e-05	CbGpPWpGaD
Promethazine—CHRM2—Signaling Pathways—AKT1—pancreatic cancer	1.99e-06	1.63e-05	CbGpPWpGaD
Promethazine—ADRA1A—Signaling Pathways—AKT1—pancreatic cancer	1.99e-06	1.62e-05	CbGpPWpGaD
Promethazine—CALM2—Metabolism—AKT1—pancreatic cancer	1.95e-06	1.59e-05	CbGpPWpGaD
Promethazine—CALM1—Metabolism—AKT1—pancreatic cancer	1.95e-06	1.59e-05	CbGpPWpGaD
Promethazine—CALM2—Signaling Pathways—TP53—pancreatic cancer	1.93e-06	1.58e-05	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—TP53—pancreatic cancer	1.93e-06	1.58e-05	CbGpPWpGaD
Promethazine—CALM3—Signaling Pathways—HRAS—pancreatic cancer	1.91e-06	1.56e-05	CbGpPWpGaD
Promethazine—ABCB1—Metabolism—PIK3CA—pancreatic cancer	1.87e-06	1.53e-05	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—HRAS—pancreatic cancer	1.84e-06	1.51e-05	CbGpPWpGaD
Promethazine—CALM2—Signaling Pathways—HRAS—pancreatic cancer	1.84e-06	1.51e-05	CbGpPWpGaD
Promethazine—CYP2D6—Metabolism—PIK3CA—pancreatic cancer	1.76e-06	1.44e-05	CbGpPWpGaD
Promethazine—CYP2C9—Metabolism—PIK3CA—pancreatic cancer	1.75e-06	1.43e-05	CbGpPWpGaD
Promethazine—CALM3—Signaling Pathways—AKT1—pancreatic cancer	1.68e-06	1.38e-05	CbGpPWpGaD
Promethazine—CALM2—Signaling Pathways—AKT1—pancreatic cancer	1.63e-06	1.33e-05	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—AKT1—pancreatic cancer	1.63e-06	1.33e-05	CbGpPWpGaD
Promethazine—ABCB1—Metabolism—AKT1—pancreatic cancer	1.53e-06	1.25e-05	CbGpPWpGaD
Promethazine—CYP2D6—Metabolism—AKT1—pancreatic cancer	1.44e-06	1.18e-05	CbGpPWpGaD
Promethazine—CYP2C9—Metabolism—AKT1—pancreatic cancer	1.43e-06	1.17e-05	CbGpPWpGaD
